2019
DOI: 10.1016/j.jtv.2019.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Understanding the development of advanced wound care in the UK: Interdisciplinary perspectives on care, cure and innovation

Abstract: Contemporary wound care in the UK has developed into two distinct complex wound care management spheres. The acute wound characterised by the contemporary, aggressive management of major trauma, and chronic wound care where there is widespread use of the term 'advanced' although, arguably its methods remain largely traditional [1]. Chronic wound care in the UK has now few connections with the more specialised systems that have developed for less prevalent burns and also for dermatological conditions [2,3]. Mos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
14
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 48 publications
2
14
0
1
Order By: Relevance
“…These findings are consistent with what Madden (2012) documented within contemporary wound care, which is dominated by product-focused innovation and education despite historical evidence demonstrating that the organisation of care is at least as important to patient outcomes (Madden & Stark, 2019). Rather, industry-authored education finds synergy with a biomedical model that neglects the social and organisational determinants of poor health outcomes (Madden & Stark, 2019). Similarly, population oral health is heavily determined by socioeconomic and commercial influences, yet, health systems and research are oriented towards high-technology, treatment-focused approaches (Peres et al, 2019).…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…These findings are consistent with what Madden (2012) documented within contemporary wound care, which is dominated by product-focused innovation and education despite historical evidence demonstrating that the organisation of care is at least as important to patient outcomes (Madden & Stark, 2019). Rather, industry-authored education finds synergy with a biomedical model that neglects the social and organisational determinants of poor health outcomes (Madden & Stark, 2019). Similarly, population oral health is heavily determined by socioeconomic and commercial influences, yet, health systems and research are oriented towards high-technology, treatment-focused approaches (Peres et al, 2019).…”
Section: Discussionsupporting
confidence: 90%
“…For example, when hospitals seek to purchase equipment, devices or medical products, the provision of educational support is often perceived as a “value add” and point of competition among companies (Miller et al, 2019). Industry representatives routinely provide product‐ and practice‐related education accompanying the introduction of new drugs, products and equipment into hospitals as well as ongoing product education and support in the form of “lunch n’ learns,” targeted in‐services and sponsorship of continuing education (Grundy, 2018; Jutel & Menkes, 2009; Madden & Stark, 2019). Industry sustains its presence in clinical settings through the provision of educational materials including research syntheses, product information sheets, brochures, posters and teaching materials, which nurses rely on to support clinical and purchasing decisions and for their own practice supports (Grundy, 2016, 2018; Jutel & Menkes, 2009).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The relationships between these different groups have at times been fraught with tension due to differing perspectives and commercial interests, specifically with regard to the use of evidence to inform practice, which affects the quality of wound care that patients receive. 8,10,16 From an intellectual perspective, each group of people interested in improving the quality of wound trials can be considered a community of practice. [17][18][19][20] This conceptualisation is appropriate because people who belong to the research community decide what may be considered a good trial.…”
Section: Improving Clinical Trialsmentioning
confidence: 99%